{Reference Type}: Journal Article
{Title}: Optical genome mapping for prenatal diagnosis: A prospective study.
{Author}: Goumy C;Guy Ouedraogo Z;Soler G;Eymard-Pierre E;Laurichesse H;Delabaere A;Gallot D;Bouchet P;Perthus I;Pebrel-Richard C;Gouas L;Salaun G;Salse J;Véronèse L;Tchirkov A;
{Journal}: Clin Chim Acta
{Volume}: 551
{Issue}: 0
{Year}: 2023 Nov 1
{Factor}: 6.314
{DOI}: 10.1016/j.cca.2023.117594
{Abstract}: <B>OBJECTIVE: </B>Cytogenetic analysis provides important information for prenatal decision-making and genetic counseling. Optical genome mapping (OGM) has demonstrated its performances in retrospective studies. In our prospective study, we assessed the quality of DNA obtained from cultures of amniotic fluid (AF) and chorionic villi (CV) and evaluated the ability of OGM to detect all clinically relevant aberrations identified by standard methods.<BR><B>METHODS: </B>A total of 37 prenatal samples from pregnancies with a fetal anomaly on ultrasound were analyzed prospectively by OGM between January 1, 2021 and June 31, 2022. OGM results were interpreted blindly and compared to the results obtained by standard techniques.<BR><B>RESULTS: </B>OGM results were interpretable in 92% of samples. We observed 100% concordance between OGM and karyotype and/or chromosomal microarray results. In addition, OGM identified a median of 30 small (<100 kb) structural variations per case with the involvement of 12 OMIM genes, of which 3 were OMIM morbid genes.<BR><B>CONCLUSIONS: </B>This prospective study showed OGM performed well in detecting genomic alterations in cell cultures from prenatal samples. The place of OGM in relation to CMA or exome sequencing remains to be defined in order to optimize the prenatal diagnostic procedure.